Loading...
5 Recombinant Products Reports
Study Period: 2017- 2028
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, Latin America
Major Players: Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Biocon, Zhuhai United Laboratories Co., Ltd.
Study Period: 2018 - 2028
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: New England Biolabs, GlaxoSmithKline plc, Pfizer, Sanofi, GenScript
Study Period: 2018-2028
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Eli Lilly and Company, Thermo Fisher Scientific Inc., Novartis AG, GlaxoSmithKline PLC, Pfizer Inc.
Study Period: 2018 - 2028
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Eli Lilly and Company, Ferring Pharmaceuticals, F.Hoffmann-La Roche Ltd (Genentech, Inc), Merck & Co Inc (Merck KGaA), Pfizer Inc
Study Period: 2018 - 2028
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players: Transgene SA, Sorrento Therapeutics, Inc., Amgen, CG Oncology Inc, Oncolys BioPharma
Filter Reports
By Region
By Countries
